BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 8157053)

  • 1. Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.
    Vanderah T; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Hruby VJ; Haaseth RC; Matsunaga TO; Porreca F
    Eur J Pharmacol; 1994 Feb; 252(2):133-7. PubMed ID: 8157053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
    Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
    Mattia A; Farmer SC; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Bowen WD; Porreca F
    J Pharmacol Exp Ther; 1992 Feb; 260(2):518-25. PubMed ID: 1310737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens.
    Wild KD; Carlisi VJ; Mosberg HI; Bowen WD; Portoghese PS; Sultana M; Takemori AE; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1993 Feb; 264(2):831-8. PubMed ID: 8382281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of [D-Ala2, Glu4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor.
    Bilsky EJ; Bernstein RN; Pasternak GW; Hruby VJ; Patel D; Porreca F; Lai J
    Life Sci; 1994; 55(2):PL37-43. PubMed ID: 8015351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive effects of [D-Ala2]deltorphin II, a highly selective delta agonist in vivo.
    Qi JA; Mosberg HI; Porreca F
    Life Sci; 1990; 47(11):PL43-7. PubMed ID: 2170791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of antinociceptive efficacy of intracerebroventricular [D-Ala2,Glu4]deltorphin, but not [D-Pen2,D-Pen5]enkephalin, in the mu-opioid receptor deficient CXBK mouse.
    Raffa RB; Martinez RP; Porreca F
    Eur J Pharmacol; 1992 Jun; 216(3):453-6. PubMed ID: 1330585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat.
    Ossipov MH; Kovelowski CJ; Nichols ML; Hruby VJ; Porreca F
    Pain; 1995 Sep; 62(3):287-293. PubMed ID: 8657428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudoirreversible binding characteristics of [D-Ala2,Glu4]deltorphin and its Cys4 substituted derivative to delta-opioid receptors.
    Wild KD; Horan PJ; Misicka A; Lipkowski A; Haaseth RC; Matsunaga TO; Hruby VJ; Toth G; Borsodi A; Yamamura HI
    Eur J Pharmacol; 1993 Jun; 246(1):25-31. PubMed ID: 8394818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.
    Mattia A; Vanderah T; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1991 Aug; 258(2):583-7. PubMed ID: 1650835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
    Qi JA; Bowen WD; Mosberg HI; Rothman RB; Porreca F
    J Pharmacol Exp Ther; 1990 Nov; 255(2):636-41. PubMed ID: 2173752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of multiple intracerebroventricular injections of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin II on tolerance to their analgesic action and on brain delta-opioid receptors.
    Zhao GM; Bhargava HN
    Brain Res; 1997 Jan; 745(1-2):243-7. PubMed ID: 9037415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
    Stewart PE; Hammond DL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
    Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
    Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of some 7-arylidene and 7-heteroarylidene morphinan-6-ones on the antinociceptive activity of [D-Pen2, D-Pen5]enkephalin and [D-Ala2, Glu4]deltorphin II and on multiple opioid receptors.
    Bhargava HN; Zhao GM; Bian JT; Nan Y; Upadhyaya SP; Xu W; Dunn WJ; Bauer L
    Peptides; 1997; 18(5):695-701. PubMed ID: 9213363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.
    Horan PJ; Wild KD; Misicka A; Lipkowski A; Haaseth RC; Hruby VJ; Weber SJ; Davis TP; Yamamura HI; Porreca F
    J Pharmacol Exp Ther; 1993 May; 265(2):896-902. PubMed ID: 8388462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic administration of 7-benzylidene-7-dehydronaltrexone and naltriben on the antinociceptive actions of delta 1- and delta 2-opioid receptor agonists.
    Bhargava HN; Zhao GM; House RV; Thomas PT
    Eur J Pharmacol; 1996 Sep; 311(2-3):127-32. PubMed ID: 8891592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with antisense oligodeoxynucleotide to the opioid delta receptor selectively inhibits delta 2-agonist antinociception.
    Lai J; Bilsky EJ; Rothman RB; Porreca F
    Neuroreport; 1994 May; 5(9):1049-52. PubMed ID: 8080957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors.
    Porreca F; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI
    J Pharmacol Exp Ther; 1992 Oct; 263(1):147-52. PubMed ID: 1328602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
    Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.